Search - tctmd.com

Displaying 201 - 220 of 235

Sort: Relevancy | Date

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

Meta-analysis Supports Endovascular Therapy for Acute Stroke

Nicole Lou

June 23, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Todd Neale

June 22, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Jason Kahn

July 20, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

Advertisement

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

Meta-analysis Supports Endovascular Therapy for Acute Stroke

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

TCTMD’s Top 10 Most Popular News Stories for 2014

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

TCTMD’s Top 10 Most Popular News Stories for 2013

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Evidence Continues to Support Dabigatran Treatment in A-fib

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content